SonoVue Guided Prostate Biopsy

Summary

This is a phase III European multicenter, open label, prospective study to assess the diagnostic accuracy of the use of SonoVue contrast agent to guide prostate biopsies in comparison with the current practice of ultrasound guided systematic biopsy. The trial will involve 15-20 European Centers.

Timeline

Start

2009-02

Primary completion

2011-03

Completion

2011-03

Outcome

Outcome not reported

Stopped: “Failure to meet primary objective”

Drugs

Indications